Thiamine chloride-Echo (Capsules) Instructions for Use
Marketing Authorization Holder
NPC Ekho, CJS (Russia)
Contact Information
NPC Ekho, CJSC (Russia)
ATC Code
A11DA01 (Thiamine)
Active Substance
Thiamine (Rec.INN WHO registered)
Dosage Form
| Thiamine chloride-Echo | Capsules 100 mg: 30 pcs. |
Dosage Form, Packaging, and Composition
Capsules are hard gelatin, size №0, yellow in color; the capsule contents are a powder white or white with a creamy tint, with a characteristic odor.
| 1 ml | |
| Thiamine chloride (vit. B1) | 100 mg |
Excipients: potato starch, refined sugar.
30 pcs. – polymer bottles.
Clinical-Pharmacological Group
B vitamin
Pharmacotherapeutic Group
Vitamin preparation
Pharmacological Action
Vitamin B.
Vitamin B1 is a coenzyme of the most important enzymes – transaldolases and transketolases, which mainly catalyze carbohydrate metabolism processes, has a positive effect on the conduction of nerve impulses by influencing polarization in the area of neuromuscular synapses.
It plays an important role in carbohydrate, protein, and fat metabolism, and protects cell membranes from the toxic effects of lipid peroxidation products.
Pharmacokinetics
Absorption
Absorption is high, throughout the entire small intestine. Before absorption, thiamine chloride is released from its bound state by digestive enzymes. The concentration of thiamine chloride in the blood is relatively low.
Distribution
Free thiamine is predominantly found in the plasma, while its phosphate esters are found in erythrocytes and leukocytes. Half of the total amount is contained in striated muscles (including the myocardium) and about 40% is in the internal organs.
Metabolism
Phosphorylation occurs in the liver. The most active phosphate ester is thiamine diphosphate, which has coenzyme activity. It accumulates mainly in the liver, heart, brain, kidneys, and spleen.
Excretion
It is excreted through the intestines and kidneys.
Indications
- Monotherapy for the treatment of hypovitaminosis and avitaminosis B1;
- As part of complex therapy for polyneuritis, dystrophic myocardial lesions, chronic liver lesions, Wernicke’s encephalopathy (Korsakoff’s psychosis);
- As part of complex therapy for alcohol and opioid dependence.
ICD codes
| ICD-10 code | Indication |
| E51 | Thiamine deficiency |
| E51.1 | Beriberi |
| E51.2 | Wernicke's encephalopathy |
| F10.2 | Chronic alcoholism |
| F11 | Mental and behavioral disorders due to opioid use |
| G60 | Hereditary and idiopathic neuropathy |
| G61 | Inflammatory polyneuropathy |
| G62.1 | Alcoholic polyneuropathy |
| G63.2 | Diabetic polyneuropathy |
| ICD-11 code | Indication |
| 5B5A.0Z | Beriberi, unspecified |
| 5B5A.10 | Wernicke's encephalopathy |
| 5B5A.Z | Vitamin B1 deficiency, unspecified |
| 6C40.2Z | Alcohol dependence, unspecified |
| 6C40.Z | Disorders due to alcohol use, unspecified |
| 6C43.Z | Disorders due to opioid use, unspecified |
| 8C01.Z | Inflammatory polyneuropathy, unspecified |
| 8C03.0 | Diabetic polyneuropathy |
| 8C2Y | Other specified hereditary neuropathy |
| 8C4Z | Disorders of nerve roots, plexuses or peripheral nerves, unspecified |
| 8D44.0 | Alcoholic polyneuropathy |
| 8D44.Y | Other specified alcohol-related neurological disorders |
Dosage Regimen
| The method of application and dosage regimen for a specific drug depend on its form of release and other factors. The optimal dosage regimen is determined by the doctor. It is necessary to strictly adhere to the compliance of the dosage form of a specific drug with the indications for use and dosage regimen. |
Take the drug orally.
For the treatment of mild to moderate thiamine deficiency, administer one 100 mg capsule once daily.
For severe deficiency states, including Wernicke’s encephalopathy, the dosage is one 100 mg capsule two to three times daily.
In cases of alcoholic polyneuropathy and dystrophic myocardial lesions, use one capsule once daily for a duration of two to three weeks.
For the management of alcohol or opioid dependence, prescribe one capsule two to three times daily for three to four weeks.
Adjust the duration of therapy based on clinical response and the underlying condition being treated.
Do not exceed the recommended daily dosage without medical supervision.
Swallow the capsule whole with a sufficient amount of water; do not chew or crush.
Adverse Reactions
Allergic reactions rarely – skin itching, urticaria, angioedema.
Contraindications
- Hypersensitivity to the components of the drug.
Use in Pregnancy and Lactation
Data on the use of the drug during pregnancy and lactation are not provided.
Special Precautions
No special instructions for the drug are provided.
Overdose
Data on drug overdose are not provided.
Drug Interactions
Data on drug interactions are not provided.
Storage Conditions
The drug should be stored out of the reach of children, in a dry, light-protected place at a temperature from 18°C (64.4°F) to 20°C (68°F).
Shelf Life
Shelf life – 3 years.
Dispensing Status
The drug is approved for use as an over-the-counter product.
Important Safety Information
This information is for educational purposes only and does not replace professional medical advice. Always consult your doctor before use. Dosage and side effects may vary. Use only as prescribed.
Medical Disclaimer